Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-β-lactamase in two tertiary-care teaching hospitals

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 4, 2006, Pages 882-885

  Zavascki, Alexandre Prehn ^a,b   Barth, Afonso Luís ^b,c   Gaspareto, Patrick Barcelos ^c   Gonçalves, Ana Lúcia Saraiva ^c   Moro, Ana Lúcia Didonet ^a   Fernandes, Juliana Fernandez ^b   Goldani, Luciano Zurbaran ^b,c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

lactamases; Bacterial drug resistance; Case control studies; Fluoroquinolones; Multiple bacterial drug resistance; P. aeruginosa; SPM 1 lactamase

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; ERTAPENEM; GENTAMICIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUTROPENIA; NONHUMAN; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; TEACHING HOSPITAL; TERTIARY HEALTH CARE; URINARY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; FLUOROQUINOLONES; HOSPITALS, TEACHING; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS;

EID: 33748681703     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl327     Document Type: Article

References (14)

1. Walsh TR, Toleman MA, Poirel L et al. Metallo-β-lactamases: The quiet before the storm? Clin Microbiol Rev 2005; 18: 306-25.
2. Zavascki AP, Barth AL, Gorçalves ALS et al. The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 2006; 58: 387-92.
3. Zavascki AP, Gaspareto PB, Martins AF et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother 2005; 56: 1148-51.
4. Hirakata Y, Yamaguchi T, Nakano M et al. Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis 2003; 37: 26-32.
5. Nouér SA, Nucci M, de-Oliveira MP et al. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. Antimicrob Agents Chemother 2005; 49: 3663-7.
6. Garner JS, Jarvis WR, Emori TG et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-40.
7. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-83.
8. Beaber JW, Hochhut B, Waldor MK. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 2004; 427: 72-4.
9. Zavascki AP, Cruz RP, Goldani LZ. Risk factors for imipenem-resistant Pseudomonas aeruginosa: A comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect 2005; 59: 96-101.
10. Defez C, Fabbro-Peray P, Bouziges N et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect 2004; 57: 209-16.
11. Conejo MC, Garcia I, Martinez-Martinez L et al. Zinc eluted from siliconized latex urinary catheters decreases OprD expression, causing carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2003; 47: 2313-5.
12. Aloush V, Navon-Venezia S, Seigman-Igra Y et al. Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact. Antimicrob Agents Chemother 2006; 50: 43-8.
13. Harris AD, Karchmer TB, Carmeli Y et al. Methodological principles of case-control studies that analysed risk factors for antibiotic resistance: A systematic review. Clin Infect Dis 2001; 32: 1055-61.
14. Zavascki AP. Assessing risk factors for acquiring antimicrobial-resistant pathogens: A time for a comparative approach. Clin Infect Dis 2004; 39: 871-2.